Delivery Order SPE2DB20D2104-SPE2DB24FU76H

Award Date 6/18/24
Potential Completion Date 6/20/24
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, to provide ENTECAVIR 0.5 MG TABLET 30S. The $1,137 Firm Fixed Price Delivery Order contract has a completion date of November 20, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
This federal contract award, valued at $2,375.97, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the delivery of 4563269031 - ENTECAVIR 0.5 MG TABLET 30S. The contract has an ultimate completion date of January 9, 2024 and is a Firm Fixed Price Delivery Order. The award is not associated with a set-aside program. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying...
This federal contract award is a delivery order with a firm fixed price valued at $2,244.95, issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ENTECAVIR 0.5 MG TABLET 30S, with a completion date of August 6, 2024. There was no set-aside designation for this award. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of ENTECAVIR 0.5 MG TABLET 30S. The $5,407.01 firm fixed-price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,203.97 firm fixed-price delivery order is for the supply of ENTECAVIR 0.5 MG TABLET 30S, a pharmaceutical product, with a period of performance through April 2, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award, with ID SPE2DB22D3016|SPE2DB24FACE5, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,400.59 firm fixed-price delivery order is for the supply of 4562692286 ENTECAVIR 0.5 MG TABLET 30S, with a completion date of November 3, 2023. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,320.34 delivery order contract is a Firm Fixed Price (FFP) agreement to provide ENTECAVIR 0.5 MG TABLET 30S for the government. The contract has an ultimate completion date of January 27, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ENTECAVIR 0.5 MG TABLET 30S, a medication, with a ceiling value of $2,236.42. The contract is a Firm Fixed Price arrangement and is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,704.03 firm fixed-price delivery order is for the supply of 4567538526 - ENTECAVIR 0.5 MG TABLET 30S. The contract has an ultimate completion date of March 12, 2025 and was awarded on March 11, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,600.99 firm fixed-price delivery order is for the supply of ENTECAVIR 0.5 MG TABLET 30S, a generic prescription medication. The award has an ultimate completion date of March 6, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB24FU76H
    Delivery Order

This federal contract award SPE2DB20D2104|SPE2DB24FU76H, valued at $1,401.99, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the delivery of ENTECAVIR 0.5 MG TABLET 30S. The contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation, indicating open competition.

AmerisourceBergen Drug Corporation is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government agencies, including the military and veterans' healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/17/25, 10:05 AM